| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute pulmonary embolism with and without hemodynamic instability (2003-2022): a Swiss nationwide epidemiologic study
|
Wolf, Simon
|
|
|
23 |
4 |
p. 1340-1351
|
artikel
|
| 2 |
A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear
|
Cao, Wenjing
|
|
|
23 |
4 |
p. 1229-1240
|
artikel
|
| 3 |
Annoucements
|
|
|
|
23 |
4 |
p. 1458-1459
|
artikel
|
| 4 |
Applying artificial intelligence to uncover the genetic landscape of coagulation factors
|
Soldà, Giulia
|
|
|
23 |
4 |
p. 1133-1145
|
artikel
|
| 5 |
Basics of diagnosis and treatment of venous thromboembolism
|
Cox, Catrin
|
|
|
23 |
4 |
p. 1185-1202
|
artikel
|
| 6 |
Choosing the optimal oral anticoagulant for stroke prevention in atrial fibrillation: direct oral anticoagulants vs vitamin K antagonists
|
Carlin, Stephanie
|
|
|
23 |
4 |
p. 1207-1214
|
artikel
|
| 7 |
Corrigendum to ‘FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic’
|
Lentz, Steven R.
|
|
|
23 |
4 |
p. 1456-1457
|
artikel
|
| 8 |
Description of the clinical and radiological characteristics of pulmonary embolism in COVID-19 vs non–COVID-19 patients: a multicentric cross-sectional study over a 24-month perspective
|
Sterpone, Paola
|
|
|
23 |
4 |
p. 1332-1339
|
artikel
|
| 9 |
“Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world data”: comment from Karlaftis et al.
|
Karlaftis, Vasiliki
|
|
|
23 |
4 |
p. 1452-1453
|
artikel
|
| 10 |
“Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world data”: reply
|
Lalos, Natasha
|
|
|
23 |
4 |
p. 1454-1455
|
artikel
|
| 11 |
Exosite crosstalk in thrombin
|
Fredenburgh, James C.
|
|
|
23 |
4 |
p. 1160-1168
|
artikel
|
| 12 |
Fibrin film on clots is increased by hematocrit but reduced by inflammation: implications for platelets and fibrinolysis
|
Alkarithi, Ghadir
|
|
|
23 |
4 |
p. 1247-1259
|
artikel
|
| 13 |
From bench to bedside: the role of tailoring fibrinolysis in pulmonary embolism
|
Maginot, Elizabeth R.
|
|
|
23 |
4 |
p. 1205-1206
|
artikel
|
| 14 |
Gut microbiome dysbiosis is not associated with portal vein thrombosis in patients with end-stage liver disease: a cross-sectional study
|
Aleksandrova, Rali R.
|
|
|
23 |
4 |
p. 1407-1415
|
artikel
|
| 15 |
Impact of coincident lower extremity deep vein thrombosis on symptomatic and incidental pulmonary embolism outcomes. A single-center prospective cohort study
|
Callori, Steven
|
|
|
23 |
4 |
p. 1260-1268
|
artikel
|
| 16 |
Implementation of the ISTH Framework for Professional Conduct
|
Scarlatescu, Ecaterina
|
|
|
23 |
4 |
p. 1131-1132
|
artikel
|
| 17 |
Intravenous tenecteplase bridging reperfusion ameliorates cerebral ischemia/reperfusion injury by improving microvascular circulation in rats
|
Ning, Yue-Xin
|
|
|
23 |
4 |
p. 1352-1366
|
artikel
|
| 18 |
Issue Information
|
|
|
|
23 |
4 |
p. e1-e6
|
artikel
|
| 19 |
Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of ischemic stroke
|
Hald, Erin Mathiesen
|
|
|
23 |
4 |
p. 1401-1406
|
artikel
|
| 20 |
Mice with reduced protease-activated receptor 4 reactivity show decreased venous thrombosis and platelet procoagulant activity
|
Knauss, Elizabeth A.
|
|
|
23 |
4 |
p. 1278-1288
|
artikel
|
| 21 |
New targets for antithrombotic medications: seeking to decouple thrombosis from hemostasis
|
Barnes, Geoffrey D.
|
|
|
23 |
4 |
p. 1146-1159
|
artikel
|
| 22 |
Peak and trough concentrations of apixaban and rivaroxaban in adult patients: a systematic review and meta-analysis
|
Almalbis, Christian Andrew
|
|
|
23 |
4 |
p. 1289-1314
|
artikel
|
| 23 |
Progesterone regulates gut microbiota mediating bone marrow mesenchymal stem cell injury in immune thrombocytopenia patients during pregnancy
|
Chen, Qi
|
|
|
23 |
4 |
p. 1428-1441
|
artikel
|
| 24 |
Prolonged vs standard thromboprophylaxis in patients with esophageal cancer undergoing surgery: a randomized controlled study
|
Gyldenholm, Tua
|
|
|
23 |
4 |
p. 1367-1378
|
artikel
|
| 25 |
Replacement of a single residue changes the primary specificity of thrombin
|
Dei Rossi, Alessia
|
|
|
23 |
4 |
p. 1241-1246
|
artikel
|
| 26 |
Risk of ischemic stroke after cancer diagnosis: a population-based matched cohort study
|
Siegal, Deborah M.
|
|
|
23 |
4 |
p. 1269-1277
|
artikel
|
| 27 |
Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism
|
Bezerra, Ohanna C.L.
|
|
|
23 |
4 |
p. 1379-1392
|
artikel
|
| 28 |
Structure-resolved dynamics of type 2M von Willebrand disease
|
Tischer, Alexander
|
|
|
23 |
4 |
p. 1215-1228
|
artikel
|
| 29 |
Systematic analysis of the design, methodology, and patient population characteristics of the pediatric direct oral anticoagulant trials of venous thromboembolism treatment
|
Betensky, Marisol
|
|
|
23 |
4 |
p. 1315-1331
|
artikel
|
| 30 |
The individual fibrinolytic capacity predicts the efficacy of ultrasound-assisted catheter-directed thrombolysis in patients with acute pulmonary embolism
|
Draxler, Dominik F.
|
|
|
23 |
4 |
p. 1416-1427
|
artikel
|
| 31 |
Therapeutic plasma exchange for fibrinogen-associated hyperviscosity: results of the COVID-19 PLasma EXchange (COPLEX) randomized controlled trial
|
Maier, Cheryl L.
|
|
|
23 |
4 |
p. 1393-1400
|
artikel
|
| 32 |
Therapeutic potential of roxadustat in immune thrombocytopenia: a Mendelian randomization analysis
|
Ma, Jingyao
|
|
|
23 |
4 |
p. 1442-1451
|
artikel
|
| 33 |
Thrombin reveals new faces with a tiny trick
|
De Cristofaro, Raimondo
|
|
|
23 |
4 |
p. 1203-1204
|
artikel
|
| 34 |
Tolerance to factor VIII in the era of nonfactor therapies: immunologic perspectives and a systematic review of the literature
|
van Stam, Lilianne Esmée
|
|
|
23 |
4 |
p. 1169-1184
|
artikel
|
Tijdschrift beschrijving